Loading...
Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy
BACKGROUND: Adoptive cell therapy with T cells genetically engineered to express a chimeric antigen receptor (CAR-T) or tumor-infiltrating T lymphocytes (TIL) demonstrates impressive clinical results in patients with cancer. Lymphodepleting preconditioning prior to cell infusion is an integral part...
Saved in:
| Published in: | J Immunother Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BMJ Publishing Group
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8127974/ https://ncbi.nlm.nih.gov/pubmed/33990415 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001743 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|